KaliVir Immunotherapeutics, Inc.
KaliVir Immunotherapeutics, Inc.28KaliVir Immunotherapeutics, Inc.
Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
About
What does KaliVir Immunotherapeutics, Inc. do?
KaliVir Immunotherapeutics is a clinical-stage biotechnology company focused on developing innovative, multi-mechanistic oncolytic immunotherapy programs. The company leverages its proprietary Vaccinia Enhanced Template (VET™) platform to engineer vaccinia viruses that selectively replicate in and kill cancer cells, while also stimulating anti-tumor immunity and modifying the tumor microenvironment. Their product candidates are designed for systemic intravenous delivery to treat various cancer t…
What is KaliVir Immunotherapeutics, Inc.'s Effective Domain Rating?
StartupHub's Effective Domain Rating for KaliVir Immunotherapeutics, Inc. is 9 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is fairly rated against its Ahrefs Domain Rating of 10.
Is KaliVir Immunotherapeutics, Inc. trustworthy and reputable?
StartupHub's Data Trust & Reputation score for KaliVir Immunotherapeutics, Inc. is 52 out of 100, based on site security posture and privacy practices.
What is KaliVir Immunotherapeutics, Inc.'s revenue?
StartupHub estimates KaliVir Immunotherapeutics, Inc.'s annual revenue at $3.3M (range $2.0M to $11.1M, 68% confidence), based on comparable companies in the sector.
What is KaliVir Immunotherapeutics, Inc.'s valuation?
StartupHub estimates KaliVir Immunotherapeutics, Inc.'s effective valuation at $977.2M (range $684.1M to $1.3B, 42% confidence), based on comparable companies in the sector.
How much funding has KaliVir Immunotherapeutics, Inc. raised?
KaliVir Immunotherapeutics, Inc. has raised a total of $14M in funding. The most recent round on record is Series A Extension.
Where is KaliVir Immunotherapeutics, Inc. headquartered?
KaliVir Immunotherapeutics, Inc. is headquartered in Pittsburgh, United States.
When was KaliVir Immunotherapeutics, Inc. founded?
KaliVir Immunotherapeutics, Inc. was founded in 2019.
What industry does KaliVir Immunotherapeutics, Inc. operate in?
KaliVir Immunotherapeutics, Inc. operates in Biotechnology, Health, Pharmaceuticals, Oncology, Biotech, MedTech.
How many employees does KaliVir Immunotherapeutics, Inc. have?
KaliVir Immunotherapeutics, Inc. has approximately 29 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
“SIGA | SIGA Announces Oncology Collaboration with KaliVir Immunotherapeutics.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.